Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 40901-40950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05880121
Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatric Lupus
N/ARecruiting
200 participants
Started: Apr 30, 2023 · Completed: Apr 29, 2026
1 condition2 sponsors1 location
NCT06675266
AIRFRAME: Artificial Intelligence for Recognition of Fetal bRain AnoMaliEs at Second Trimester Fetal Brain Scan
N/ARecruiting
10,000 participants
Started: Apr 30, 2023 · Completed: Dec 30, 2026
2 conditions3 sponsors1 location
NCT06186882
Gene x Environment Interplay in Developmental Dyslexia Treatment: A Round-trip Translation Between Humans and Animal
NARecruiting
60 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05738499
The Effectiveness and Mechanism of Character Strengths-based STEP Programme on Rehabilitation of Stroke Patients
NARecruiting
172 participants
Started: Apr 30, 2023 · Completed: Dec 30, 2023
4 conditions1 sponsor1 location
NCT05000749
DBT Skills Groups for Veterans at High Risk for Suicide Attempt
NARecruiting
172 participants
Started: Apr 30, 2023 · Completed: Feb 26, 2027
1 condition1 sponsor5 locations
NCT05850611
The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer
EARLY_PHASE1Recruiting
20 participants
Started: Apr 30, 2023 · Completed: Sep 21, 2024
2 conditions1 sponsor1 location
NCT05613608
Alcohol Use Disorder and Cannabidiol
PHASE2/PHASE3Recruiting
180 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT06814314
AP Metabolism Transcriptomics
N/ARecruiting
100 participants
Started: Apr 30, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05827835
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
PHASE1/PHASE2Recruiting
30 participants
Started: Apr 30, 2023 · Completed: Apr 25, 2027
2 conditions2 sponsors1 location
NCT05799690
Comparison of Different Rehabilitation Protocols in Parkinson's Disease With Postural Instability and Gait Disorders
NARecruiting
80 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT05795335
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
N/ARecruiting
172 participants
Started: Apr 30, 2023 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05440851
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NARecruiting
6,250 participants
Started: Apr 30, 2023 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT05843552
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
N/ARecruiting
30 participants
Started: Apr 30, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05749393
Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm
NARecruiting
90 participants
Started: Apr 30, 2023 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT05286892
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
NARecruiting
128 participants
Started: Apr 30, 2023 · Completed: Dec 15, 2026
2 conditions2 sponsors2 locations
NCT05244564
Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial
NARecruiting
60 participants
Started: Apr 30, 2023 · Completed: Oct 30, 2027
1 condition3 sponsors1 location
NCT05828251
Full Thickness Macular Hole; Should it be Handled Subacutely?
NARecruiting
56 participants
Started: Apr 30, 2023 · Completed: Apr 1, 2028
1 condition1 sponsor1 location
NCT05834855
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
PHASE3Recruiting
200 participants
Started: Apr 30, 2023 · Completed: May 31, 2027
6 conditions2 sponsors1 location
NCT05830227
Evaluation of Infrared Thermal Imaging in Diagnosis of OSAHS in Children
N/ARecruiting
80 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06344650
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
N/ARecruiting
100 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition3 sponsors1 location
NCT05918094
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE3Recruiting
540 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor10 locations
NCT05758844
The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA
N/ARecruiting
100 participants
Started: Apr 30, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05828225
Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis
PHASE1Recruiting
9 participants
Started: Apr 30, 2023 · Completed: Apr 20, 2026
1 condition1 sponsor1 location
NCT05617859
Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
PHASE2Recruiting
60 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06167603
Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories
N/ARecruiting
140 participants
Started: Apr 30, 2023 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT05353452
Collaborative Care in Posttraumatic Epilepsy
NARecruiting
60 participants
Started: Apr 30, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06514690
Postoperative Memories and Level of Sedation for Tracheal Intubation Using Fiberoptic Bronchoscopy/Videolaryngoscopy
N/ARecruiting
100 participants
Started: Apr 29, 2023 · Completed: May 29, 2025
3 conditions1 sponsor2 locations
NCT05866640
Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EARLY_PHASE1Recruiting
10 participants
Started: Apr 29, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT05989386
Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies
PHASE2/PHASE3Recruiting
200 participants
Started: Apr 29, 2023 · Completed: Dec 29, 2025
8 conditions1 sponsor1 location
NCT05720507
Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty
NARecruiting
36 participants
Started: Apr 29, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05930184
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
PHASE2/PHASE3Recruiting
98 participants
Started: Apr 29, 2023 · Completed: Dec 31, 2024
6 conditions1 sponsor1 location
NCT05688696
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
PHASE2Recruiting
186 participants
Started: Apr 29, 2023 · Completed: May 30, 2026
1 condition1 sponsor41 locations
NCT06169631
The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology
NARecruiting
100 participants
Started: Apr 29, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06297538
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
NARecruiting
84 participants
Started: Apr 29, 2023 · Completed: Apr 29, 2026
1 condition3 sponsors1 location
NCT05698628
Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO
NARecruiting
400 participants
Started: Apr 28, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05615636
A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
PHASE2Recruiting
36 participants
Started: Apr 28, 2023 · Completed: Aug 19, 2027
3 conditions1 sponsor1 location
NCT05626608
Continuous Electrical Neuromodulation of the Globus Pallidus Intern in Parkinson's Disease by the Directional Electrode CARTESIA™
NARecruiting
10 participants
Started: Apr 28, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05788120
Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock
N/ARecruiting
600 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06695416
Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX
N/ARecruiting
500 participants
Started: Apr 28, 2023 · Completed: Apr 28, 2025
2 conditions1 sponsor1 location
NCT05866783
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
N/ARecruiting
500 participants
Started: Apr 28, 2023 · Completed: Jan 1, 2038
4 conditions4 sponsors1 location
NCT05835245
Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)
PHASE2Recruiting
30 participants
Started: Apr 28, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04991870
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PHASE1Recruiting
25 participants
Started: Apr 28, 2023 · Completed: Jan 31, 2027
3 conditions2 sponsors1 location
NCT06114082
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
PHASE2Recruiting
128 participants
Started: Apr 28, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06202235
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
N/ARecruiting
100 participants
Started: Apr 28, 2023 · Completed: Dec 8, 2026
1 condition1 sponsor1 location
NCT05205980
Perturbation Training Reduces Falls in People With AD
NARecruiting
30 participants
Started: Apr 28, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05761028
A Study of CM310 in Subjects With Moderate to Severe Asthma
PHASE2/PHASE3Recruiting
600 participants
Started: Apr 28, 2023 · Completed: May 31, 2032
1 condition1 sponsor1 location
NCT05818384
Wakaya: Rising Up for Choctaw Youth Health
NARecruiting
176 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
4 conditions2 sponsors2 locations
NCT05841563
Clinical Trial of PM54 in Advanced Solid Tumors Patients.
PHASE1Recruiting
125 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor3 locations
NCT05797558
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
NARecruiting
80 participants
Started: Apr 28, 2023 · Completed: May 28, 2028
1 condition3 sponsors3 locations
NCT05789485
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
PHASE2Recruiting
216 participants
Started: Apr 28, 2023 · Completed: Apr 18, 2027
1 condition1 sponsor8 locations